114 related articles for article (PubMed ID: 34636797)
1. Routine Use of Biomarkers to Rationalize Antibiotic Use During Febrile Episodes in Pediatric Bone Marrow Transplantation Units.
Toro JF; Peña E; Ramírez O; López P; Portilla CA; López-Medina E
Pediatr Infect Dis J; 2021 Nov; 40(11):1023-1028. PubMed ID: 34636797
[TBL] [Abstract][Full Text] [Related]
2. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
[TBL] [Abstract][Full Text] [Related]
4. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients.
Cabanillas Stanchi KM; Queudeville M; Malaval C; Feucht J; Schlegel P; Dobratz M; Seitz C; Müller I; Lang P; Handgretinger R; Döring M
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2779-2791. PubMed ID: 31446489
[TBL] [Abstract][Full Text] [Related]
5. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients?
Massaro KS; Macedo R; de Castro BS; Dulley F; Oliveira MS; Yasuda MA; Levin AS; Costa SF
Infection; 2014 Dec; 42(6):1023-32. PubMed ID: 25263811
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of serum procalcitonin and C-reactive protein for infections after allogeneic hematopoietic stem cell transplantation versus nontransplant setting.
Mori Y; Miyawaki K; Kato K; Takenaka K; Iwasaki H; Harada N; Miyamoto T; Akashi K; Teshima T
Intern Med; 2011; 50(19):2149-55. PubMed ID: 21963733
[TBL] [Abstract][Full Text] [Related]
7. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin and C-reactive protein predict infection in hematopoietic stem cell transplantation patients.
Li S; Gu J; Nan W; Zhang N; Qin L; Su M; Jia M
Leuk Res; 2021 Jun; 105():106574. PubMed ID: 33836480
[TBL] [Abstract][Full Text] [Related]
9. [C reactive protein and procalcitonin levels for the diagnosis of invasive bacterial infections in allogenic hematopoietic stem cell transplantation recipients].
Schmidt N; Palma J; King A; Santolaya ME
Rev Med Chil; 2007 Aug; 135(8):982-9. PubMed ID: 17989854
[TBL] [Abstract][Full Text] [Related]
10. [Use of procalcitonin and C-reactive protein as infection markers in febrile neutropenic patients undergoing haematopoietic stem cell transplant].
Sánchez-Yepes M; Aznar-Oroval E; Lorente-Alegre P; García-Lozano T; Picón-Roig I; Pérez-Ballestero P; Ortiz-Muñoz B
Enferm Infecc Microbiol Clin; 2014; 32(7):418-23. PubMed ID: 24269102
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of procalcitonin in adults with non-neutropenic fever after allogeneic hematopoietic stem cell transplantation.
Ortega M; Rovira M; Filella X; Martínez JA; Almela M; Puig J; Carreras E; Mensa J
Bone Marrow Transplant; 2006 Mar; 37(5):499-502. PubMed ID: 16415895
[TBL] [Abstract][Full Text] [Related]
12. Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation.
Ortega M; Rovira M; Almela M; de la Bellacasa JP; Carreras E; Mensa J
Bone Marrow Transplant; 2004 Apr; 33(7):741-4. PubMed ID: 14730343
[TBL] [Abstract][Full Text] [Related]
13. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell Transplantation.
Shan M; Shen D; Song T; Xu W; Qiu H; Chen S; Han Y; Tang X; Miao M; Sun A; Wu D; Xu Y
Front Immunol; 2022; 13():843067. PubMed ID: 35547733
[TBL] [Abstract][Full Text] [Related]
15. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
[TBL] [Abstract][Full Text] [Related]
16. Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study.
Downes KJ; Fitzgerald JC; Schriver E; Boge CLK; Russo ME; Weiss SL; Balamuth F; Kubis SE; Tolomeo P; Bilker WB; Han JH; Lautenbach E; Coffin SE; Gerber JS
J Pediatric Infect Dis Soc; 2020 Feb; 9(1):36-43. PubMed ID: 30476186
[TBL] [Abstract][Full Text] [Related]
17. Performance of C-reactive protein and procalcitonin to distinguish viral from bacterial and malarial causes of fever in Southeast Asia.
Lubell Y; Blacksell SD; Dunachie S; Tanganuchitcharnchai A; Althaus T; Watthanaworawit W; Paris DH; Mayxay M; Peto TJ; Dondorp AM; White NJ; Day NP; Nosten F; Newton PN; Turner P
BMC Infect Dis; 2015 Nov; 15():511. PubMed ID: 26558692
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.
Talaya A; Giménez E; Vinuesa V; Pérez A; Amat P; Piñana JL; Albert E; Hernández-Boluda JC; Solano C; Navarro D
Med Microbiol Immunol; 2019 Aug; 208(3-4):405-414. PubMed ID: 30911925
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of procalcitonin in febrile infants younger than 3 months of age visiting a pediatric emergency room: a retrospective single-center study.
Park JS; Byun YH; Lee JY; Lee JS; Ryu JM; Choi SJ
BMC Pediatr; 2021 Mar; 21(1):109. PubMed ID: 33663442
[TBL] [Abstract][Full Text] [Related]
20. Comparison of interleukin-6, interleukin-10, procalcitonin and C-reactive protein in identifying high-risk febrile illness in pediatric cancer patients: A prospective observational study.
Xu XJ; Luo ZB; Xia T; Song H; Yang SL; Xu WQ; Ni YR; Ning Zhao ; Tang YM
Cytokine; 2019 Apr; 116():1-6. PubMed ID: 30684912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
